Eidos Therapeutics Inc (EIDX) Stock Analyst Ratings

NASDAQ:EIDX

122.21
-6.23 (-4.85%)
At close: Jan 25, 2021
120.235
-1.97 (-1.62%)
After Hours: 1/25/2021, 8:00:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

55

ChartMill assigns a Buy % Consensus number of 55% to EIDX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • EIDX was analyzed by 8 analysts. The buy percentage consensus is at 55. So analysts seem to be rather neutral about EIDX.
  • In the previous month the buy percentage consensus was at a similar level.
  • EIDX was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
EIDX Historical Analyst RatingsEIDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6
EIDX Current Analyst RatingEIDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades

Eidos Therapeutics Inc / EIDX FAQ

What is the consensus rating for Eidos Therapeutics Inc (EIDX) stock?

The consensus rating for Eidos Therapeutics Inc (EIDX) is 55 / 100 . This indicates that analysts generally have a neutral outlook on the stock.